Anna Skowron
CFO & TreasurerMs. Anna Skowron, CPA, CA, is Chief Financial Officer of GeoVax Labs, Inc. from November 16, 2026. Ms. Skowron is CFO & Treasurer of BioRestorative Therapies, Inc. from August 27, 2026. She was Chief Financial Officer of Nuclea Energy Inc. from December 9, 2025 until August 2026. She is Chief Financial Officer of Powell Max Limited from January 30, 2026. Ms. Skowron is Interim Chief Financial Officer of GridAI Technologies Corp. (Formerly known as Entero Therapeutics, Inc.) from March 7, 2025. She served as CFO & Company Secretary of Titan Environmental Solutions Inc since April 15, 2025 until February 9, 2026. She is a Principal at Skowron Accounting Professional Corporation, which was founded in 2015. With years of accounting related experience, Ms. Skowron specializes in financial reporting, compliance, corporate governance and business strategy. Ms. Skowron is Interim Chief Financial Officer of Entero Therapeutics, Inc. from March 7, 2025. Ms. Skowron served as Global Financial Controller at a multi-national North American domiciled technology provider. Her professional reach was further expanded in 2025 through her appointments as Chief for XRP Healthcare, announced on July 9, 2025. She also managed consolidated reporting across North America for a global steel corporation. Ms. Skowron has played a key role in various business acquisitions and capital raising initiatives across multiple industries. Ms. Skowron was the chief financial officer of Titan from April 2025 until her resignation on February 9, 2026. Ms. Skowron holds a Bachelor of Commerce and Finance with specialization in Accounting and Economics from the University of Toronto and became a member of the Institute of Chartered Accounts of Ontario in 2014.
公司職務
- 公司名稱BioRestorative Therapies, Inc.股票代碼BRTX職務CFO & Treasurer
- 公司名稱GeoVax Labs, Inc.股票代碼GOVX職務Chief Financial Officer共事同僚
- MJMark J. NewmanChief Scientific Officer
- TOTyler O’BrienInterim CEO & Chairman of the Board
- ASAnna SkowronChief Financial Officer
- TOThomas O’BrienVice President of Quality Systems & Compliance
- JWJeffrey WelchHead of Process Development & Manufacturing Operations
- RTRobert T. McNallyIndependent Director
- DADavid Alan DoddDirector
- TLTeresa LambeInfectious Disease & Vaccine Scientific Advisory Board Member
- LTLance TurtleInfectious Disease & Vaccine Scientific Advisory Board Member
- 公司名稱Powell Max Limited股票代碼PMAX職務Chief Financial Officer
- 公司名稱GridAI Technologies Corp.股票代碼GRDX職務Interim Chief Financial Officer
